​​Name: Rubuo' Bisan Drugstore & Medical Supplies​

Collaborator:  Feras Al Tarifi

Collaborating with pharmaceutical company which focus on the development of therapeutics to treat human diseases align very well with our research interest in search for anticancer and anti-inflammatory drug development. Toxicological studies and metabolites analysis can be performed at Rubuo' Bisan company as they are equipped with instruments such as LC-MS-MS/Liquid Chromatography which is needed to complete part of biological properties of our developing drugs.  ​​

Name: Department of Biomedicine, Aarhus University, Denmark

Collaborator: Dr. Holger Bruggemann / Associate Professor of Microbiology​

Collaborating with microbiologists who focus on the skin microbiome and its metabolites could significantly enrich my research on anti-inflammatory mechanisms. The skin microbiome plays a crucial role in modulating local immune responses, and its metabolites can influence inflammatory pathways that are central to various systemic diseases. By integrating their expertise in microbiome composition and metabolite production with my focus on cellular inflammation, we can explore how microbial metabolites impact immunity and contribute to inflammatory conditions. This interdisciplinary approach could lead to novel insights and therapeutic strategies for managing inflammation and promoting human health.

This collaboration will open new avenues for innovative research ideas and discoveries by bridging the gap between cell biology, anti-inflammatory mechanisms, and microbiome science. By combining expertise in microbiome metabolites—both gut and skin—with my focus on cellular inflammation, we can uncover novel pathways through which microbiota influence immune responses. This synergy has the potential to reveal groundbreaking insights into the role of the microbiome in inflammatory diseases and may lead to the development of new therapeutic strategies, fostering a deeper understanding of the complex interactions between host cells and microbial communities in health and disease.​